Stress-Echography in Hereditary Haemorrhagic Telangiectasia Patient With Hepatic Involvement (ROSE)
Hereditary Hemorrhagic Telangiectasia, Rendu Osler Disease
About this trial
This is an interventional diagnostic trial for Hereditary Hemorrhagic Telangiectasia focused on measuring HHT, Stress echography, Pulmonary arterial pressures
Eligibility Criteria
Inclusion Criteria: HHT patient > 18 yo Hepatic involvement (hepatic artery diameter > 6mm) Patient having received the information and signed the informed consent form Patient affiliated to a social security scheme or beneficiaries of a similar scheme Exclusion Criteria: Haemoglobin < 90 g/L Active Infection Atrial Fibrillation permanent or persistent Known cardiopathy Pregnant or breastfeeding woman (by questioning) Adult subject to a legal protection measure (guardianship) Participation in another clinical trial that may interfere with the proposed trial (investigator judgment) Patient physically unable to pedal Patient with Pulmonary arteriovenous malformations awaiting embolization Patient treated with beta-blockers Secondary Exclusion Criteria verified on rest ultrasound PAH (Pulmonary Arterial Hypertension) at rest (Vmax > 2.8 m/sec) Inability to obtain a stream of IT at rest Patient with atrial fibrillation (AF)
Sites / Locations
- Service Explorations fonctionnelles cardiovasculaires - Hôpital Louis PradelRecruiting
- Service génétique - Hôpital Femme Mère EnfantRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
HHT patients with hepatic involvement and high cardiac index
HHT patients with hepatic involvement and normal cardiac index
HHT patients with a dilated (diameter > 6mm) or tortuous hepatic artery and an elevated cardiac index (> 3.5 l/mn/m²)
HHT patients with a dilated or tortuous hepatic artery and a normal cardiac index